corytuberine has been researched along with aristolochic acid i in 1 studies
*aristolochic acid I: phospholipase A inhibitor [MeSH]
*aristolochic acid I: phospholipase A inhibitor [MeSH]
| Studies (corytuberine) | Trials (corytuberine) | Recent Studies (post-2010) (corytuberine) | Studies (aristolochic acid i) | Trials (aristolochic acid i) | Recent Studies (post-2010) (aristolochic acid i) |
|---|---|---|---|---|---|
| 9 | 0 | 1 | 1,088 | 2 | 548 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borges, S; Chan, TM; Fischmann, T; Gullo, VP; Hegde, VR; Kirschmeier, P; Madison, V; Patel, M; Pu, H; Williams, MJ; Wu, B | 1 |
1 other study(ies) available for corytuberine and aristolochic acid i
| Article | Year |
|---|---|
Semi-synthetic aristolactams--inhibitors of CDK2 enzyme.
Topics: Aristolochic Acids; CDC2 Protein Kinase; Cell Line, Tumor; Computer Simulation; Crystallography, X-Ray; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Pyrazoles; Quinolines; Structure-Activity Relationship | 2010 |